Table 4.
Name of the drug | Possible mechanism | Outcome |
---|---|---|
Allopurinol and Febuxostat (XO inhibitors) | Inhibition of XO and shunting 6-MP to 6-TGN formation | Myelosuppression |
5-Aminosalicylates | TPMT inhibition | Myelosuppression |
Warfarin | Possibly increased metabolism/decreased absorption | Decreased warfarin efficacy |
ACE inhibitors | Poorly understood | Myelosuppression and anemia |
Loop diuretics | TPMT inhibition | Myelosuppression |
Ribavirin | IMPDH inhibition | Myelosuppression |
Chemotherapeutic agents | Likely additive effect on cytotoxicity of sinusoidal cells | Sinusoidal obstruction syndrome/veno-occlusive disease |
XO, xanthine oxidase; ACE, angiotensin converting enzyme; 6-MP, 6-mercaptopurine; 6-TGN, 6-thioguanine nucleotides; TPMT, thiopurine-S-methyltransferase; IMPDH, inosine monophosphate dehydrogenase.